Norges Bank acquired a new stake in Amgen, which is listed on Nasdaq and subject to required filings with the Securities and Exchange Commission.
2 reports, 1 independent
Updated Aug 26
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Norges Bank acquired a new stake in Amgen, which is listed on Nasdaq and subject to required filings with the Securities and Exchange Commission.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Norges Bank acquired a new stake in Amgen shares, and Amundi boosted its position in the company.Sub-event
Norges Bank acquired a stake in Amgen, which is listed on Nasdaq and subject to SEC filings.1 source
Keep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Norges Bank
central bank of Norway
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- Norges Bank acquired a new position in Amrize stock, and Bank of America restated its rating and price targets for the company.
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Norges Bank bought shares of UnitedHealth Group, prompting the company to file required reports with the SEC.
- Norges Bank acquired a stake in Verisign, a company listed on Nasdaq.